30 December 2011
Microchimerism after pancreas and kidney transplantation – a review
Małgorzata Zagozda, Agnieszka Sarnecka, Marek DurlikAnn Transplant 2011; 16(4): 134-137 :: ID: 882231
Abstract
The main cause of a negative response to grafting is immune rejection connected with a reaction to the donor’s antigens. The process of rejecting transplanted organs is a whole-body process. The reaction of the organism begins when the donor’s antigens reach the recipient’s lymphatic organs via blood or lymph. The donor’s genetic material (DNA) is detected in the recipient’s blood and lymphoid tissues even a few months after transplant rejection. Microchimerism occurs when in an individual patient the cells and genetic material from both the donor and recipient are present and the cell count of one of these is overrepresented. Such situations can occur after blood transfusions, grafts or pregnancies. It is suggested that this phenomenon could have an influence on tolerance, prolonged graft survival or the rejection process. The results of many experiments are thus far equivocal; therefore further research is needed elucidate the process and mechanisms of graft rejection and its molecular aspects.
Keywords: microchimerism, Pancreas, Kidney, transplant
In Press
Original article
Urinary Chemokines CXCL9 and CXCL10 Are Non-Invasive Biomarkers of Kidney Transplant RejectionAnn Transplant In Press; DOI: 10.12659/AOT.944762
Original article
Risk Factors for Graft Failure After Penetrating Keratoplasty in Eastern China from 2018 to 2021Ann Transplant In Press; DOI: 10.12659/AOT.945388
Original article
Predictive Model for Post-Transplant Renal Fibrosis Using Ultrasound Shear Wave ElastographyAnn Transplant In Press; DOI: 10.12659/AOT.945699
Original article
The Long-Acting Glucagon-Like Peptide-2 Analog Apraglutide Enhances Intestinal Protection and Survival Afte...Ann Transplant In Press; DOI: 10.12659/AOT.945249
Most Viewed Current Articles
05 Apr 2022 : Original article 12,973
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 10,069
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
12 Jan 2022 : Original article 9,412
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
15 Mar 2022 : Case report 7,175
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860